Andrew Fuglevand is using artificial intelligence to stimulate multiple muscles to elicit natural movement in ways previous methods have been unable to do.

A clinical trial at the UA Cancer Center in Phoenix will be the first to use immunotherapy as a primary treatment option for liver cancer.

UA scientists hope they have made progress toward a next-generation drug that may slow tumor growth and boost radiation’s effectiveness in patients with the deadly brain cancer.

Researchers at the UA Cancer Center hope early-phase clinical trials will lead to new treatment options for melanoma patients with BRAF or MEK mutations.

Dr. Michael Kruer has received the first federally funded grant to research genetic causes of a condition that affects 1 in 250 children.

Banner Health has launched new clinical practice protocols developed with input from the UA Valley Fever Center for Excellence to help physicians more quickly diagnose and treat patients with Valley fever infections.

A $2 million grant from the U.S. Department of Defense will support research on 3D-printed scaffolds that support the repair of devastating bone injuries.

Individuals with a particular genetic factor may be more resistant to plaque build-up and have a reduced risk for coronary artery disease, according to study completed by a team of physicians, geneticists and biologists.

The gift from UA alumnus Peter Salter and his wife, Nancy, will fund a biomedical instrument design studio and corresponding course development at the UA College of Engineering.

The University of Arizona Cancer Center is building a robust tobacco-cessation program to provide support to tobacco users hoping to quit.